Dermal Fillers :
As we age, our faces naturally lose subcutaneous fat. The facial muscles are then working closer to the skin surface, so smile lines and crow’s feet become more apparent.
What are dermal fillers used for ?
- Plump thin lips.
- Enhance shallow contours.
- Soften facial creases and wrinkles.
- Improve the appearance of recessed scars.
- Reconstruct contour deformities in the face.
- Decrease or remove the shadow of the lower lids.
- Dermal fillers can be very helpful in those with early signs of aging, or as a value-added part of facial rejuvenation surgery.
What are some types of dermal fillers ?
There are several different types of dermal fillers. The most common types are:
Calcium hydroxylapatite (CaHA)
Calcium hydroxylapatite is also a naturally occurring substance, found primarily in our bones. The consistency of a CaHA filler is typically thicker than that of a hyaluronic acid filler and typically last longer as well, about 12 months for most patients.
Hyaluronic acid (HA)
HA fillers are typically soft and gel-like. The results last 6 to 12 months or longer before the body gradually and naturally absorbs the particles.
Hyaluronic acid injections can be used to improve the skin’s contour and reduce depressions in the skin due to scars, injury or lines. These will typically last from 6 to 18 months. Injections to the lips will wear out a little faster than those to the nasolabial folds. Certain HA fillers, such as VOLUMA, are formulated to last longer, but are usually limited to certain areas, such as the cheeks.
- Polylactic acid is a synthetic dermal filler that is injected into your face, causing your body’s own production of collagen. This type of dermal filler is known as a stimulator.
- This substance is unlike other dermal fillers because it doesn’t produce immediate results. Instead, it stimulates your own body’s collagen production, so results appear gradually over a period of a few months.
Polymethyl-methacrylate microspheres (PMMA)
PMMA is considered a semi-permanent filler and is most often used to treat medium-to-deep wrinkles, folds and furrows, particularly nasolabial folds. It can also be used to fill out pitted scars and to augment thin lips.
JUVÉDERM VOLUMA® XC
UVÉDERM VOLUMA® XC
Is a volumizing Filler, mainly composed of Hyaluronic Acid, a product we have in our body that goes away as we age. This product immediately restores facial volume to smooth out the signs of aging. The product is slowly re-absorbed into your body and results fade away gracefully. Results last from 3 months to 2 years, depending on the thickness of filler that is used and where it is placed.
Safety Information :
JUVÉDERM VOLUMA® XC
JUVÉDERM VOLUMA® XC injectable gel is indicated for deep (subcutaneous and/or supraperiosteal) injection for cheek augmentation to correct age-related volume deficit in the mid-face in adults over the age of 21.
IMPORTANT SAFETY INFORMATION
These products should not be used in patients who have severe allergies, marked by a history of anaphylaxis or history or presence of multiple severe allergies, and should not be used in patients with a history of allergies to Gram-positive bacterial proteins or lidocaine contained in these products.
- Do not inject into blood vessels. Introduction of these products into the vasculature may lead to embolization, occlusion of the vessels, ischemia, or infarction. Take extra care when injecting soft-tissue fillers; for example, inject the product slowly and apply the least amount of pressure necessary. Rare, but serious, adverse events associated with the intravascular injection of soft-tissue fillers in the face have been reported and include temporary or permanent vision impairment, blindness, cerebral ischemia or cerebral hemorrhage leading to stroke, skin necrosis, and damage to underlying facial structures. Immediately stop the injection if a patient exhibits any of the following symptoms: changes in vision, signs of a stroke, blanching of the skin, unusual pain during or shortly after the procedure. Patients should receive prompt medical attention and, possibly, evaluation by an appropriate healthcare professional specialist should an intravascular injection occur.
- Product use at specific sites in which an active inflammatory process (skin eruptions such as cysts, pimples, rashes, or hives) or infection is present should be deferred until the underlying process has been controlled.
- In order to minimize the risk of potential complications, these products should only be used by healthcare professionals who have appropriate training, experience, and knowledge of facial anatomy.
- Healthcare professionals are encouraged to discuss the potential risks of soft-tissue injections with their patients prior to treatment and ensure that patients are aware of signs and symptoms of potential complications.
- The safety and effectiveness for the treatment of anatomic regions other than moderate to severe facial wrinkles and folds with JUVÉDERM® Ultra XC and JUVÉDERM® Ultra Plus XC, the lips and perioral area for lip augmentation with JUVÉDERM® Ultra XC, the mid-face with JUVÉDERM VOLUMA® XC, and the lips and perioral area for lip augmentation and correction of perioral rhytids with JUVÉDERM VOLBELLA® XC have not been established in controlled clinical studies.
- As with all transcutaneous procedures, dermal filler implantation carries a risk of infection. Follow standard precautions associated with injectable materials.
- The safety for use during pregnancy, in breastfeeding females, and in patients with known susceptibility to keloid formation, hypertrophic scarring, and pigmentation disorders has not been studied.
- The safety for use of JUVÉDERM® Ultra XC and JUVÉDERM® Ultra Plus XC in patients under 18 years, JUVÉDERM VOLUMA® XC in patients under 35 or over 65 years, and JUVÉDERM VOLBELLA® XC in patients under 22 years has not been established.
- Use with caution in patients on immunosuppressive therapy.
- Patients who are using products that can prolong bleeding (such as aspirin, nonsteroidal anti-inflammatory drugs, and warfarin) may experience increased bruising or bleeding at treatment sites.
- If laser treatment, chemical peel, or any other procedure based on active dermal response is considered after treatment, or if the product is administered before the skin has healed completely, there is a possible risk of an inflammatory reaction at the treatment site.
- Patients who experience skin injury near the site of implantation may be at a higher risk for adverse events.
- The safety of JUVÉDERM VOLUMA® XC injectable gel for use in patients with very thin skin in the mid-face has not been established.
- Patients may experience late onset nodules with use of dermal fillers, including JUVÉDERM VOLUMA® XC.
- Patients may experience late onset adverse events with use of dermal fillers, including JUVÉDERM VOLBELLA® XC.
- The most commonly reported side effects for JUVÉDERM® injectable gels were temporary injection-site redness, swelling, pain/tenderness, firmness, lumps/bumps, bruising, discoloration, and itching. For JUVÉDERM VOLBELLA® XC, dryness was also reported. For JUVÉDERM® Ultra XC or JUVÉDERM® Ultra Plus XC, side effects were mostly mild or moderate in severity, with a duration of 14 days or less; for JUVÉDERM VOLUMA® XC, they were predominantly moderate in severity, with a duration of 2 to 4 weeks; and for JUVÉDERM VOLBELLA® XC, they were predominantly mild or moderate, with a duration of 30 days or less.
- To report an adverse reaction with JUVÉDERM® Ultra XC, JUVÉDERM® Ultra Plus XC, JUVÉDERM VOLUMA® XC, or JUVÉDERM VOLBELLA® XC, please call Allergan at 1-800-433-8871. Please also visit JuvedermDFU.com for more information.
- JUVÉDERM® Ultra XC, JUVÉDERM® Ultra Plus XC, JUVÉDERM VOLUMA® XC, and JUVÉDERM VOLBELLA® XC injectable gels are available by prescription only.
Before and After Treatment